Development of Carbon Monoxide Rebreathing to Estimate Blood Volume

Overview

About this study

The goal of the project is to develop and implement the optimized carbon monoxide rebreathing techniquein order to estimate blood volume.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

  • Healthy normotensive male and non-pregnant female subjects between the ages of 18-80

Exclusion Criteria: 

  • Current smoker
  • Impaired respiratory function (COPD, asthma, etc.)
  • Cardiovascular/bleeding disorders
  • On any current medication (excluding birth control pills)

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Michael Joyner, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20309535

Mayo Clinic Footer